Importance of stem cell therapy – Video
By raymumme
Importance of stem cell therapy
By: StemCellVN
Originally posted here:
Importance of stem cell therapy - Video
Adventist Hospital offers stem cell therapy
By Sykes24Tracey
THE Davao Adventist Hospital is now offering services for autologous stem cell therapy.
Marketing officer Kim Endrei Go said the therapy is the first in Davao City and an alternative treatment for degenerative diseases of joints and bones caused by sports injuries and chronic pains.
Go said the treatment allows the patient to continue the normal routine even after the treatment. He said the therapy is non-surgical and has a healing period of only three days.
The modalities in extracting stem cells in the therapy are either through the Platelet Rich Plasma (PRP) and through Bone Marrow Aspiration Concentrate.
Go said autologous means that the stem cells will be extracted from the patient himself and will be regenerated through an equipment.
The hospital uses the Harvest technologies from the United States which introduced the SmartPrePtm2.
SmartPrePtm2 is used to redefine platelet concentrate systems. Its latest innovation will further expand and enhance the use of autologous bioactive proteins as well as help optimize the condition for healing.
Go said that the therapy session depends on the severeness of the patient's condition. He added that most patients had 3 sessions but some had once or twice.
He said the technology was first practice in their Cebu branch and is now adopted for Davao. He said that in Cebu there about almost 90 treatments since November last where it was launched.
Each session costs P80,000 where about 60 cc of platelet and stem cells will be collected from the patient.
Originally posted here:
Adventist Hospital offers stem cell therapy
Stem Cell Therapy Treatment for Myotonic Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. – Video
By JoanneRUSSELL25
Stem Cell Therapy Treatment for Myotonic Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 3 months after Stem Cell Therapy Treatment for Myotonic Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy...
By: NeuroGen Brain And Spine Institute
The rest is here:
Stem Cell Therapy Treatment for Myotonic Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video
Stem Cell Therapy Treatment for Becker Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. – Video
By JoanneRUSSELL25
Stem Cell Therapy Treatment for Becker Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Improvement seen after Stem Cell Therapy Treatment for Becker Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. Stem Cell Therapy done at Dr Alok Sharma N...
By: NeuroGen Brain And Spine Institute
Go here to read the rest:
Stem Cell Therapy Treatment for Becker Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video
Brodie Before
By daniellenierenberg
Brodie Before After Stemlogix Stem Cell Therapy
Brodie a 3 year old rottweiler had a complete cranial cruciate ligament tear of his left rear leg. Dr. Stephanie Meyer at the Creatures Great Small Vet Hos...
By: Stemlogix LLC #39;s Channel
View post:
Brodie Before
VetRegen stem cell therapy. – Video
By NEVAGiles23
VetRegen stem cell therapy.
Please watch this Video though in Polish most is visual. I took out the longer news cast that was Filmed Live in Warsaw My wife Joanna was asked too be on a ...
By: stephen sanford
Original post:
VetRegen stem cell therapy. - Video
Stem Cell Therapy A New Investigational Approach To Arthritis Relief – Video
By daniellenierenberg
Stem Cell Therapy A New Investigational Approach To Arthritis Relief
http://www.innovationsstemcellcenter.com 214.699.6948.
By: InnovationsStemCell
Read more:
Stem Cell Therapy A New Investigational Approach To Arthritis Relief - Video
UK & World News: Stem cell therapy 'shows results'
By NEVAGiles23
May 27 2013
Five stroke victims have shown small signs of recovery following pioneering stem cell therapy.
Prof Keith Muir, of Glasgow University, said the results were "not what we would have expected" from the group of patients who had previously shown no indications of their conditions improving.
The trial involved injecting stem cells directly into the damaged parts of the patients' brains, with the hope that they would turn into healthy tissue or "kick-start" the body's own repair processes.
Frank Marsh, 80, one of the nine patients taking part in the trial at Glasgow's Southern General Hospital, told the BBC he had seen improvements in the use of his left hand.
"I can grip certain things that I never gripped before, like the hand rail at the baths, with my left hand as well as my right," he said."It still feels fairly weak and it's still a wee bit difficult to co-ordinate, but it's much better than it was." He added: "I'd like to get back to playing my piano."
His wife Claire said: "He had reached a plateau and wasn't really improving (after his stroke). But following the operation he is able to do things he couldn't do before, such as make coffee, dressing and holding on to things."
The study involved patients who suffered strokes some time ago and had shown no signs of making any further spontaneous improvement.
Prof Muir said the results were "at the present time not what we would have expected in this group but far from being able to say whether it's something specifically related to the cells".
He told BBC Radio 4's Today programme: "We know that some of the cells will survive and potentially turn into relevant tissue. We also suspect that a large part of what we do is kick-starting repair processes that are already present in the body. So there's probably a mixture of things going on. Quite what it is that's happening in the patients, we won't know for some time to come."
Continued here:
UK & World News: Stem cell therapy 'shows results'
Stroke victims show signs of recovery following pioneering stem cell therapy
By Sykes24Tracey
Five stroke victims have shown small signs of recovery following pioneering stem cell therapy.
Prof Keith Muir, of Glasgow University, said the results were "not what we would have expected" from the group of patients who had previously shown no indications of their conditions improving.
The trial involved injecting stem cells directly into the damaged parts of the patients' brains, with the hope that they would turn into healthy tissue or "kick-start" the body's own repair processes.
Frank Marsh, 80, one of the nine patients taking part in the trial at Glasgow's Southern General Hospital, told the BBC he had seen improvements in the use of his left hand.
"I can grip certain things that I never gripped before, like the hand rail at the baths, with my left hand as well as my right," he said."It still feels fairly weak and it's still a wee bit difficult to co-ordinate but it's much better than it was."He added: "I'd like to get back to playing my piano."
His wife Claire said: "He had reached a plateau and wasn't really improving (after his stroke). But following the operation he is able to do things he couldn't do before, such as make coffee, dressing, and holding on to things."
The study involved patients who suffered strokes some time ago and had shown no signs of making any further spontaneous improvement.
Prof Muir said the results were "at the present time not what we would have expected in this group but far from being able to say whether it's something specifically related to the cells".
He told BBC Radio 4's Today programme: "We know that some of the cells will survive and potentially turn into relevant tissue. We also suspect that a large part of what we do is kick-starting repair processes that are already present in the body.
"So there's probably a mixture of things going on. Quite what it is that's happening in the patients, we won't know for some time to come."
Link:
Stroke victims show signs of recovery following pioneering stem cell therapy
Scottish News: Stem cell therapy 'shows results'
By daniellenierenberg
May 27 2013
Five stroke victims have shown small signs of recovery following pioneering stem cell therapy.
Prof Keith Muir, of Glasgow University, said the results were "not what we would have expected" from the group of patients who had previously shown no indications of their conditions improving.
The trial involved injecting stem cells directly into the damaged parts of the patients' brains, with the hope that they would turn into healthy tissue or "kick-start" the body's own repair processes.
Frank Marsh, 80, one of the nine patients taking part in the trial at Glasgow's Southern General Hospital, told the BBC he had seen improvements in the use of his left hand.
"I can grip certain things that I never gripped before, like the hand rail at the baths, with my left hand as well as my right," he said."It still feels fairly weak and it's still a wee bit difficult to co-ordinate, but it's much better than it was." He added: "I'd like to get back to playing my piano."
His wife Claire said: "He had reached a plateau and wasn't really improving (after his stroke). But following the operation he is able to do things he couldn't do before, such as make coffee, dressing and holding on to things."
The study involved patients who suffered strokes some time ago and had shown no signs of making any further spontaneous improvement.
Prof Muir said the results were "at the present time not what we would have expected in this group but far from being able to say whether it's something specifically related to the cells".
He told BBC Radio 4's Today programme: "We know that some of the cells will survive and potentially turn into relevant tissue. We also suspect that a large part of what we do is kick-starting repair processes that are already present in the body. So there's probably a mixture of things going on. Quite what it is that's happening in the patients, we won't know for some time to come."
See the original post:
Scottish News: Stem cell therapy 'shows results'
Stem cell therapy 'shows results'
By Sykes24Tracey
Five stroke victims have shown small signs of recovery following pioneering stem cell therapy.
Prof Keith Muir, of Glasgow University, said the results were "not what we would have expected" from the group of patients who had previously shown no indications of their conditions improving.
The trial involved injecting stem cells directly into the damaged parts of the patients' brains, with the hope that they would turn into healthy tissue or "kick-start" the body's own repair processes.
Frank Marsh, 80, one of the nine patients taking part in the trial at Glasgow's Southern General Hospital, told the BBC he had seen improvements in the use of his left hand.
"I can grip certain things that I never gripped before, like the hand rail at the baths, with my left hand as well as my right," he said."It still feels fairly weak and it's still a wee bit difficult to co-ordinate, but it's much better than it was." He added: "I'd like to get back to playing my piano."
His wife Claire said: "He had reached a plateau and wasn't really improving (after his stroke). But following the operation he is able to do things he couldn't do before, such as make coffee, dressing and holding on to things."
The study involved patients who suffered strokes some time ago and had shown no signs of making any further spontaneous improvement.
Prof Muir said the results were "at the present time not what we would have expected in this group but far from being able to say whether it's something specifically related to the cells".
He told BBC Radio 4's Today programme: "We know that some of the cells will survive and potentially turn into relevant tissue. We also suspect that a large part of what we do is kick-starting repair processes that are already present in the body. So there's probably a mixture of things going on. Quite what it is that's happening in the patients, we won't know for some time to come."
The stem cells were created 10 years ago from one sample of nerve tissue taken from a foetus.
Here is the original post:
Stem cell therapy 'shows results'
Gorillas And The Future of Crop Biotechnology – Biofortified Blog
By Dr. Matthew Watson
Biofortified Blog | Gorillas And The Future of Crop Biotechnology Biofortified Blog There are some really cool improvements coming along in several crops that have been developed using the tools of biotechnology – GMOs if you will. Some of these innovations have consumer health benefits. Some expand ways to encourage greater ... |
Cizzle Biotechnology – Telegraph.co.uk
By Dr. Matthew Watson
Cizzle Biotechnology Telegraph.co.uk Does the secret to early detection of lung cancer lie in a research lab in York? A small yet innovative start up biotechnology company believes its groundbreaking blood test could lead to early diagnosis and help improve treatment outcomes for lung ... |
Frontiers launches new open-access journal in Bioengineering and Biotechnology – EurekAlert (press release)
By Dr. Matthew Watson
Frontiers launches new open-access journal in Bioengineering and Biotechnology EurekAlert (press release) Frontiers, one of the world's largest and fastest growing open-access publishers, announces the launch of a new journal, Frontiers in Bioengineering and Biotechnology. A broad scope journal covering all specialties, Frontiers in Bioengineering and ... |
Generex Biotechnology Corporation (OTCMKTS:GNBT) down by 14.51%, Excel … – GSPInsider
By Dr. Matthew Watson
Generex Biotechnology Corporation (OTCMKTS:GNBT) down by 14.51%, Excel ... GSPInsider Miami, FL 05/24/2013 (GDPInsider) – Generex Biotechnology Corporation (OTCMKTS:GNBT) is trading down by about 14.51% to trade at $0.0330, with a volume of about 10.34 million shares. The introductory price for the stock for the day is $0.04 as ... Active Morning Movers - Northumberland Resources Inc (OTCMKTS:NHUR ...SBWire (press release) Nano Cap Stocks In Focus – Venaxis Inc(NASDAQ:APPY), Generex ...Techsonian (press release) |
Biotechnology ETF Investing 101 – ETF News And Commentary – NASDAQ
By Dr. Matthew Watson
Biotechnology ETF Investing 101 - ETF News And Commentary NASDAQ With ever-increasing health care spending and insatiable demand for new drugs, the biotechnology sector looks poised for good growth going forward. Furthermore, the U.S. biotech sector represents an attractive investment opportunity thanks to increased ... |
Sanford Research Team Discovers Promising Batten Disease Therapy – PR Web (press release)
By Dr. Matthew Watson
Sanford Research Team Discovers Promising Batten Disease Therapy PR Web (press release) A team from Sanford Research has discovered a potentially promising therapy for reducing the degenerative effects of Batten disease, according to a recent study published by Human Molecular Genetics. Sanford Research's Jake Miller, Chun-Hung Chan, ... |
Microbiologist at Walker Rotary meeting – Walker Pilot Independent
By Dr. Matthew Watson
Microbiologist at Walker Rotary meeting Walker Pilot Independent He has done research in food and agricultural biotechnology with Molecular Genetics Inc., Pillsbury-Green Giant and Northrup King-Novartis. Bill has co-authored two patents, authored or co-authored 14 publications in scientific books and peer-reviewed ... |
Common Food Supplement Fights Degenerative Brain Disorders, Study Suggests – Science Daily (press release)
By Dr. Matthew Watson
Times of India | Common Food Supplement Fights Degenerative Brain Disorders, Study Suggests Science Daily (press release) Gil Ast and Dr. Ron Bochner of Tel Aviv University's Department of Human Molecular Genetics has discovered that the same supplement improves the functioning of genes involved in degenerative brain disorders, including Parkinson's disease and Familial ... Phosphatidylserine Supplement Could Combat Degenerative Brain DisordersMedical Daily |
[Development of an adenovirus vector containing a hepatitis C virus expression cassette and its application].
By Dr. Matthew Watson
Authors: Yoshida T, Kondoh M, Mizuguchi H, Yagi K
Abstract
Hepatitis C virus (HCV) is a hepatotropic member of the Flaviviridae family and contains a 9.6 kb positive-sense RNA genome. Approximately 170-million people are infected with HCV worldwide. These people face increased risks of chronic hepatitis, cirrhosis and hepatocellular carcinoma compared with the general population. Transduction of the HCV genome into hepatocytes is essential for understanding the mode of action of HCV infection, and for preparing HCV, evaluating HCV replication, and screening anti-HCV drugs. Although electroporation of in vitro-synthesized HCV genome and transduction of plasmid vectors containing the HCV genome are widely used in HCV research, a more convenient system with higher transduction efficie...
MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.